LEPU MED.T.B. SP.GDR O.N. Total Liabilities

Latest as of March 2026: €7.61 Billion EUR ≈ $8.90 Billion USD

LEPU MED.T.B. SP.GDR O.N. total liabilities. Based on the latest financial reports, LEPU MED.T.B. SP.GDR O.N. (07Z0) has total liabilities worth €7.61 Billion EUR (≈ $8.90 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See LEPU MED.T.B. SP.GDR O.N. (07Z0) liquidity interval to measure how many days the company can operate on defensive assets alone.

Total Liabilities of LEPU MED.T.B. SP.GDR O.N. (2021–2025)

Total liabilities of LEPU MED.T.B. SP.GDR O.N. from 2021 to 2025. This chart illustrates how LEPU MED.T.B. SP.GDR O.N.'s total liabilities have evolved over time, based on quarterly financial data. Check 07Z0 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

LEPU MED.T.B. SP.GDR O.N. Competitors by Total Liabilities

The table below lists competitors of LEPU MED.T.B. SP.GDR O.N. ranked by their total liabilities.

Company Country Total Liabilities
Altitude Group Plc
LSE:ALT
UK GBX9.67 Million
AVILA ENERGY CORP.
F:6HQ0
Germany €22.61 Million
Cambridge Cognition Holdings Plc
LSE:COG
UK GBX9.12 Million
Sprott Physical Uranium Trust
TO:U-U
Canada $109.44 Million
Kalium Lakes Ltd
AU:KLL
Australia AU$308.00K
PDG Realty S.A. Empreendimentos e Participações
SA:PDGR3
Brazil R$3.74 Billion
ImagineAR Inc
F:GMS1
Germany €3.53 Million

Liability Composition Analysis (2021–2025)

This chart breaks down LEPU MED.T.B. SP.GDR O.N.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see LEPU MED.T.B. SP.GDR O.N. assets under control.

Liquidity & Leverage Metrics

LEPU MED.T.B. SP.GDR O.N. Total Liabilities Ratios Explained

LEPU MED.T.B. SP.GDR O.N. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.38 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.46 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.30 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how LEPU MED.T.B. SP.GDR O.N.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for LEPU MED.T.B. SP.GDR O.N. (2021–2025)

The table below shows the annual total liabilities of LEPU MED.T.B. SP.GDR O.N. from 2021 to 2025.

Year Total Liabilities Change
2025-12-31 €8.38 Billion
≈ $9.80 Billion
+6.97%
2024-12-31 €7.83 Billion
≈ $9.16 Billion
+4.09%
2023-12-31 €7.52 Billion
≈ $8.80 Billion
-7.25%
2022-12-31 €8.11 Billion
≈ $9.49 Billion
-3.70%
2021-12-31 €8.43 Billion
≈ $9.85 Billion
--

About LEPU MED.T.B. SP.GDR O.N.

F:07Z0 Germany Medical Devices
Market Cap
$174.62K
€149.36K EUR
Market Cap Rank
#31403 Global
#2790 in Germany
Share Price
€15.30
Change (1 day)
+0.00%
52-Week Range
€12.80 - €15.40
All Time High
€15.40
About

Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro d… Read more